1005788-25-9

Basic information

• Product Name: 6-IODO-IMIDAZO[1,2-B]PYRIDAZINE-2-METHANOL
• Synonyms: 6-IODO-IMIDAZO[1,2-B]PYRIDAZINE-2-METHANOL;2-(6-IODOIMIDAZO[1,2-B]PYRIDAZIN-2-YL)ETHANOL;(6-Iodo-imidazo[1,2-b]pyridazin-2-yl)-methanol
• CAS NO: 1005788-25-9
• Molecular Formula: C₇H₆IN₃O
• Molecular Weight: 289.07309
• Mol File: 1005788-25-9.mol
• Article Data: 1

Chemical Properties

• Appearance: /
• CAS DataBase Reference: 6-IODO-IMIDAZO[1,2-B]PYRIDAZINE-2-METHANOL(CAS DataBase Reference)
• NIST Chemistry Reference: 6-IODO-IMIDAZO[1,2-B]PYRIDAZINE-2-METHANOL(1005788-25-9)
• EPA Substance Registry System: 6-IODO-IMIDAZO[1,2-B]PYRIDAZINE-2-METHANOL(1005788-25-9)

Safety Data

• Hazardous Substances Data: 1005788-25-9(Hazardous Substances Data)

Upstream product

• 40235-68-5 3-chloro-2-oxopropyl acetate 
• 144-55-8 sodium hydrogencarbonate 
• 187973-60-0 6-iodopyridazine-3-amine 

Downstream Products

• 1005779-54-3 N-(3-{[2-(hydroxymethyl)imidazo[1,2-b]pyridazin-6-yl]oxy}phenyl)-1,3-dimethyl-1H-pyrazole-5-carboxamide 

Relevant articles and documents

FUSED HETEROCYCLIC DERIVATIVE AND USE THEREOF

The present invention provides a fused heterocyclic derivative having a potent kinase inhibitory activity and use thereof. A compound represented by the formula (I): wherein each symbol is as defined in the specification, except a particular compound, or a salt thereof, and a pharmaceutical agent containing the compound or a prodrug thereof, which is a kinase (VEGFR, VEGFR2, PDGFR, Raf) inhibitor, an angiogenesis inhibitor, an agent for the prophylaxis or treatment of cancer, a cancer growth inhibitor or a cancer metastasis suppressor.